A basic, Accurate, exact strategy was produced for the concurrent estimation of the Epalrestat and Pregabalin in Tablet dose shape. Chromatogram was go through Std Kromasil 250 x 4.6 mm, 5m. Portable stage containing Buffer: Acetonitrile taken in the proportion 60:40 was pumped through section at a stream rate of 1 ml/min. Cradle utilized as a part of this technique was 0.1% OPA support. Temperature was kept up at 25°C. Advanced wavelength chose was 274.0 nm. Maintenance time of Epalrestat and Pregabalin were observed to be 2.520 min and 3.745 min. %RSD of the Epalrestat and Pregabalin were and observed to be 0.4% and 0.8% separately. %Recovery was acquired as 99.87% and 99.55% for Epalrestat and Pregabalin individually. LOD, LOQ esteems got from relapse conditions of Epalrestat and Pregabalin were 0.153, 0.464 and 0.376, 1.139 separately. Relapse condition of Epalrestat is y = 5471.4x+18850, and y = 4052.9x+4585.1 of Pregabalin. Maintenance times were diminished and run time was diminished, so the strategy created was straightforward and efficient that can be received in customary Quality control test in Industries.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A basic, Accurate, exact strategy was produced for the concurrent estimation of the Epalrestat and Pregabalin in Tablet dose shape. Chromatogram was go through Std Kromasil 250 x 4.6 mm, 5m. Portable stage containing Buffer: Acetonitrile taken in the proportion 60:40 was pumped through section at a stream rate of 1 ml/min. Cradle utilized as a part of this technique was 0.1% OPA support. Temperature was kept up at 25°C. Advanced wavelength chose was 274.0 nm. Maintenance time of Epalrestat and Pregabalin were observed to be 2.520 min and 3.745 min. %RSD of the Epalrestat and Pregabalin were and observed to be 0.4% and 0.8% separately. %Recovery was acquired as 99.87% and 99.55% for Epalrestat and Pregabalin individually. LOD, LOQ esteems got from relapse conditions of Epalrestat and Pregabalin were 0.153, 0.464 and 0.376, 1.139 separately. Relapse condition of Epalrestat is y = 5471.4x+18850, and y = 4052.9x+4585.1 of Pregabalin. Maintenance times were diminished and run time was diminished, so the strategy created was straightforward and efficient that can be received in customary Quality control test in Industries. 100 pp. Englisch. N° de réf. du vendeur 9786200505552
Quantité disponible : 2 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26386244842
Quantité disponible : 4 disponible(s)
Vendeur : moluna, Greven, Allemagne
Kartoniert / Broschiert. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Chanda RanabirProf. (Dr.) Ranabir Chanda is working as principal at Sana College of Pharmacy, Kodad, Telangana, India. He has been working in different field of pharmacy profession including academic and corporate sector for 25 year. N° de réf. du vendeur 385892666
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A basic, Accurate, exact strategy was produced for the concurrent estimation of the Epalrestat and Pregabalin in Tablet dose shape. Chromatogram was go through Std Kromasil 250 x 4.6 mm, 5m. Portable stage containing Buffer: Acetonitrile taken in the proportion 60:40 was pumped through section at a stream rate of 1 ml/min. Cradle utilized as a part of this technique was 0.1% OPA support. Temperature was kept up at 25°C. Advanced wavelength chose was 274.0 nm. Maintenance time of Epalrestat and Pregabalin were observed to be 2.520 min and 3.745 min. %RSD of the Epalrestat and Pregabalin were and observed to be 0.4% and 0.8% separately. %Recovery was acquired as 99.87% and 99.55% for Epalrestat and Pregabalin individually. LOD, LOQ esteems got from relapse conditions of Epalrestat and Pregabalin were 0.153, 0.464 and 0.376, 1.139 separately. Relapse condition of Epalrestat is y = 5471.4x+18850, and y = 4052.9x+4585.1 of Pregabalin. Maintenance times were diminished and run time was diminished, so the strategy created was straightforward and efficient that can be received in customary Quality control test in Industries. N° de réf. du vendeur 9786200505552
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 393355061
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18386244832
Quantité disponible : 4 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -A basic, Accurate, exact strategy was produced for the concurrent estimation of the Epalrestat and Pregabalin in Tablet dose shape. Chromatogram was go through Std Kromasil 250 x 4.6 mm, 5m. Portable stage containing Buffer: Acetonitrile taken in the proportion 60:40 was pumped through section at a stream rate of 1 ml/min. Cradle utilized as a part of this technique was 0.1% OPA support. Temperature was kept up at 25°C. Advanced wavelength chose was 274.0 nm. Maintenance time of Epalrestat and Pregabalin were observed to be 2.520 min and 3.745 min. %RSD of the Epalrestat and Pregabalin were and observed to be 0.4% and 0.8% separately. %Recovery was acquired as 99.87% and 99.55% for Epalrestat and Pregabalin individually. LOD, LOQ esteems got from relapse conditions of Epalrestat and Pregabalin were 0.153, 0.464 and 0.376, 1.139 separately. Relapse condition of Epalrestat is y = 5471.4x+18850, and y = 4052.9x+4585.1 of Pregabalin. Maintenance times were diminished and run time was diminished, so the strategy created was straightforward and efficient that can be received in customary Quality control test in Industries.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 100 pp. Englisch. N° de réf. du vendeur 9786200505552
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. ANALYSIS OF EPLARESTAT-PRAGABALIN BY RP-HPLC | METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF EPLARESTAT-PRAGABALIN BY RP-HPLC | Ranabir Chanda | Taschenbuch | 100 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786200505552 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 117980312
Quantité disponible : 5 disponible(s)
Vendeur : Buchpark, Trebbin, Allemagne
Etat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | A basic, Accurate, exact strategy was produced for the concurrent estimation of the Epalrestat and Pregabalin in Tablet dose shape. Chromatogram was go through Std Kromasil 250 x 4.6 mm, 5m. Portable stage containing Buffer: Acetonitrile taken in the proportion 60:40 was pumped through section at a stream rate of 1 ml/min. Cradle utilized as a part of this technique was 0.1% OPA support. Temperature was kept up at 25°C. Advanced wavelength chose was 274.0 nm. Maintenance time of Epalrestat and Pregabalin were observed to be 2.520 min and 3.745 min. %RSD of the Epalrestat and Pregabalin were and observed to be 0.4% and 0.8% separately. %Recovery was acquired as 99.87% and 99.55% for Epalrestat and Pregabalin individually. LOD, LOQ esteems got from relapse conditions of Epalrestat and Pregabalin were 0.153, 0.464 and 0.376, 1.139 separately. Relapse condition of Epalrestat is y = 5471.4x+18850, and y = 4052.9x+4585.1 of Pregabalin. Maintenance times were diminished and run time was diminished, so the strategy created was straightforward and efficient that can be received in customary Quality control test in Industries. N° de réf. du vendeur 36041440/2
Quantité disponible : 1 disponible(s)